SCHEMBL20510282

SCHEMBL20510282

Cc1cccn2cc(COC(=O)n3ccnc3)nc12

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.48
MAPT P10636 5/20 0.48
RAB9A P51151 4/20 0.48
ALDH1A1 P00352 3/20 0.48
NPC1 O15118 3/20 0.48
MAPK1 P28482 2/20 0.48
POLB P06746 1/20 0.48
SMN1; SMN2 Q16637 4/20 0.47
LMNA P02545 2/20 0.47
PKM P14618 1/20 0.45
HSD17B10 Q99714 4/20 0.45
HPGD P15428 2/20 0.45
NPSR1 Q6W5P4 1/20 0.43
HRH3 Q9Y5N1 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26597475 0.80 TSHR (0.56) KDM4EMAPTRAB9AALDH1A1NPC1
SCHEMBL19973954 0.77 DPP4 (0.43) KDM4EMAPTALDH1A1MAPK1SMN1; SMN2
SCHEMBL19973982 0.72 CYP24A1 (0.35) KDM4EMAPTALDH1A1LMNAPKM
SCHEMBL19973543 0.72 SMN1; SMN2 (0.50) KDM4EMAPTRAB9AALDH1A1NPC1
SCHEMBL26597451 0.71 HDAC1 (0.34) KDM4EALDH1A1MAPK1LMNATSHR
SCHEMBL19974013 0.70 GRM2 (0.36) KDM4ERAB9AALDH1A1NPC1MAPK1
SCHEMBL20509607 0.70 PDE10A (0.47)
SCHEMBL103671 0.70 NPC1 (0.60) KDM4EMAPTRAB9AALDH1A1NPC1
SCHEMBL9570110 0.70 RAB9A (0.60) KDM4EMAPTRAB9AALDH1A1NPC1
SCHEMBL14736753 0.70 SMN1; SMN2 (0.57) KDM4EMAPTRAB9AALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3601216-B1 SUBSTITUTED DIHYDROINDENE-4-CARBOXAMIDES AND ANALOGS THEREOF, AND METHODS USING SAME FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION ARBUTUS BIOPHARMA CORP (CA) 2023-10-25 EP disclosed
EP-3601216-B1 SUBSTITUTED DIHYDROINDENE-4-CARBOXAMIDES AND ANALOGS THEREOF, AND METHODS USING SAME FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION ARBUTUS BIOPHARMA CORP (CA) 2023-10-25 EP disclosed
EP-3601216-A1 SUBSTITUTED DIHYDROINDENE-4-CARBOXAMIDES AND ANALOGS THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2020-02-05 EP disclosed
WO-2018172852-A1 SUBSTITUTED DIHYDROINDENE-4-CARBOXAMIDES AND ANALOGS THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2018-09-27 WO disclosed